N-Formyl-Met-Leu-Phe-Lys (fMLFK) is a peptide, acts as a potent and selective agonist of FPR1, with EC50s of 3.5 nM, 6.7 μM and 0.88 μM for FPR1, FPR2 and FPR2-D2817.32G, respectively.
N-Formyl-Met-Leu-Phe-Lys is a synthetic peptide that serves as a well-characterized ligand for formyl peptide receptors, particularly FPR1, in mammalian systems. Structurally, it is a tetrapeptide featuring an N-terminal formylated methionine, which is a critical motif for mimicking bacterial and mitochondrial peptide signals recognized by immune cells. Due to its high specificity and potency in activating cellular chemotaxis and signaling pathways, this peptide has become an indispensable tool in immunological, cell biology, and receptor pharmacology research. Its robust activity and defined sequence make it valuable for dissecting mechanisms of innate immune recognition, receptor-ligand interactions, and downstream cellular responses.
Chemotaxis research: As a prototypical chemoattractant, N-Formyl-Met-Leu-Phe-Lys is extensively used to investigate the migration of neutrophils, monocytes, and other phagocytic cells. By binding to formyl peptide receptors on leukocytes, it triggers directed cell movement, enabling researchers to model and quantify chemotactic responses in vitro. This application is critical for elucidating the molecular mechanisms underlying immune cell trafficking, host-pathogen interactions, and inflammatory processes, providing a foundation for understanding innate immune surveillance.
Receptor signaling studies: The peptide is widely employed to characterize the signaling cascades initiated by formyl peptide receptors, such as FPR1 and FPR2. Upon receptor engagement, it induces a series of intracellular events, including calcium mobilization, kinase activation, and reactive oxygen species production. Researchers utilize this ligand to delineate receptor specificity, G protein coupling, and downstream effectors, facilitating the development of selective agonists or antagonists for therapeutic research or drug discovery in the context of inflammation and immune modulation.
Receptor-ligand binding assays: N-Formyl-Met-Leu-Phe-Lys is a preferred probe in competitive binding assays designed to quantify receptor affinity and ligand selectivity. Its defined sequence and high-affinity binding profile make it suitable for radioligand displacement, fluorescence polarization, or surface plasmon resonance studies. These assays enable the screening of novel compounds, the assessment of receptor expression levels, and the validation of structure-activity relationships in both recombinant and native cell systems.
Functional peptide analog studies: The peptide's structure serves as a template for the design and evaluation of analogs with modified biological activity. Researchers synthesize derivatives by altering amino acid residues or modifying the N-formyl group to investigate the contribution of specific structural features to receptor recognition and activation. This approach supports the rational development of peptide-based modulators, helps map critical residues for receptor binding, and advances understanding of structure-function relationships in chemotactic peptides.
Innate immunity modeling: In experimental systems, the compound is utilized to mimic bacterial invasion signals, thereby activating pattern recognition pathways in immune cells. Its ability to simulate pathogen-associated molecular patterns (PAMPs) makes it an essential reagent for studying the activation, priming, and effector functions of phagocytes. This application contributes to the investigation of host defense mechanisms, the interplay between innate immunity and inflammation, and the identification of novel targets for immunomodulatory interventions in preclinical research.
1. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function
4. Cationic cell-penetrating peptides are potent furin inhibitors
5. Cell-based adhesion assays for isolation of snake venom’s integrin antagonists
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More